Jon P. Piganelli
Affiliations: | Immunology | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Immunology, Pathology, BiochemistryGoogle:
"Jon Piganelli"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Martha M. Sklavos | grad student | 2009 | University of Pittsburgh |
| Gina M. Coudriet | grad student | 2010 | University of Pittsburgh |
| Meghan M. Delmastro-Greenwood | grad student | 2012 | University of Pittsburgh |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lee S, Usman TO, Yamauchi J, et al. (2022) Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis. The Journal of Clinical Investigation |
| Walko TD, Di Caro V, Piganelli J, et al. (2014) Poly(ADP-ribose) polymerase 1-sirtuin 1 functional interplay regulates LPS-mediated high mobility group box 1 secretion. Molecular Medicine (Cambridge, Mass.). 20: 612-24 |
| Ramsgaard L, Englert JM, Manni ML, et al. (2011) Lack of the receptor for advanced glycation end-products attenuates e. coli pneumonia in mice Plos One. 6 |
| Chen J, Gusdon AM, Piganelli J, et al. (2011) mt-Nd2(a) Modifies resistance against autoimmune type 1 diabetes in NOD mice at the level of the pancreatic β-cell. Diabetes. 60: 355-9 |
| Su D, Coudriet GM, Hyun Kim D, et al. (2009) FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages. Diabetes. 58: 2624-33 |
| Chang Y, Yap S, Ge X, et al. (2005) DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice. Gene Therapy. 12: 1679-85 |